<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[BostonGene Corporation 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=39433></link><description><![CDATA[BostonGene Corporation 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Thu, 30 Apr 2026 23:55:12 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2021/12/12_1026003021_20211215133356_9695145881.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[BostonGene Announces $150 Million Series B Funding at a Multi-Billion Dollar Valuation, Propelling the Company to Unicorn Status]]></title><link>https://www.newswire.co.kr/newsRead.php?no=942356</link><description><![CDATA[WALTHAM, Mass.--(Business Wire/Korea Newswire)--BostonGene today announced the completion of the $150 million Series B funding. NEC Corporation (NEC; TSE: 6701) led the financing with participation from Impact Investment Capital and Japan Industrial Partners. The capital will be used to scale BostonGene’s growth, including continued innovation, clinical and research partnerships, and internat...]]></description><pubDate>Thu, 07 Apr 2022 09:55:00 +0900</pubDate></item><item><title><![CDATA[BostonGene and NEC Announce Global Partnership]]></title><link>https://www.newswire.co.kr/newsRead.php?no=936573</link><description><![CDATA[TOKYO & WALTHAM, Mass.--(Business Wire/Korea Newswire)--BostonGene Corporation and NEC Corporation (NEC; TSE: 6701) today announced a strategic global partnership agreement that will enable the companies to offer BostonGene Tumor PortraitTM Tests in key international markets, including Japan as the first market outside of the U.S.  BostonGene’s innovative computational platform performs AI-based mole...]]></description><pubDate>Wed, 15 Dec 2021 13:50:00 +0900</pubDate></item></channel></rss>